Abstract Details

Title Pharmacokinetics of USL261, a Novel Intranasal Formulation of Midazolam, in Subjects with Epilepsy

Topic Epilepsy/Clinical Neurophysiology (EEG)

Presentation(s) (-)

Poster/Presentation
Number 285

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Lindy L. Bancke, PharmD (Upsher-Smith Laboratories, Inc.) PRESENTER	No disclosure on file
Heather A. Dworak (Upsher-smith Laboratoriesclinical Development)	No disclosure on file
Mark Halvorsen, PharmD (Upsher-Smith Laboratories, LLC)	Dr. Halvorsen has received personal compensation for serving as an employee of Upsher-Smith Laboratories, LLC. Dr. Halvorsen has stock in Pfizer. Dr. Halvorsen has stock in Amgen. Dr. Halvorsen has stock in Stryker.
Savary Om	No disclosure on file